KIF5A and neoplasm: Cell colony formation experiments were employed to evaluate the proliferation ability of NCI‐H2087 cells in different treatment groups, uncovering that compared to the control group, the proliferation ability of tumor cells in the Ergotamine treatment group was considerably reduced, which was reversed by KIF5A overexpression (Figure 4D).